[HTML] nih.gov

[HTML][HTML] Neoadjuvant therapy for non-small cell lung cancer and esophageal cancer

Y He, Y Zhao, ML Akhtar, Y Li… - American Journal of …, 2024 - ncbi.nlm.nih.gov
As the major malignant tumors in the chest, non-small cell lung cancer (NSCLC) and
esophageal cancer (EC) bring huge health burden to human beings worldwide. Currently …
被引用次数：1 相关文章

Neoadjuvant therapy for non-small cell lung cancer and esophageal cancer.

Y He, Y Zhao, ML Akhtar, Y Li, H Nie - American Journal of …, 2024 - europepmc.org
As the major malignant tumors in the chest, non-small cell lung cancer (NSCLC) and
esophageal cancer (EC) bring huge health burden to human beings worldwide. Currently …

Neoadjuvant therapy for non-small cell lung cancer and esophageal cancer

Y He, Y Zhao, ML Akhtar, Y Li… - American journal of …, 2024 - pubmed.ncbi.nlm.nih.gov
As the major malignant tumors in the chest, non-small cell lung cancer (NSCLC) and
esophageal cancer (EC) bring huge health burden to human beings worldwide. Currently …

Neoadjuvant therapy for non-small cell lung cancer and esophageal cancer.

Y He, Y Zhao, ML Akhtar, Y Li, H Nie - American Journal of …, 2024 - europepmc.org
As the major malignant tumors in the chest, non-small cell lung cancer (NSCLC) and
esophageal cancer (EC) bring huge health burden to human beings worldwide. Currently …